1. Home
  2. ONCY vs VGI Comparison

ONCY vs VGI Comparison

Compare ONCY & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • VGI
  • Stock Information
  • Founded
  • ONCY 1998
  • VGI 2012
  • Country
  • ONCY Canada
  • VGI United States
  • Employees
  • ONCY N/A
  • VGI N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • VGI Investment Managers
  • Sector
  • ONCY Health Care
  • VGI Finance
  • Exchange
  • ONCY Nasdaq
  • VGI Nasdaq
  • Market Cap
  • ONCY 89.7M
  • VGI 90.1M
  • IPO Year
  • ONCY 1999
  • VGI N/A
  • Fundamental
  • Price
  • ONCY $1.11
  • VGI $7.93
  • Analyst Decision
  • ONCY Strong Buy
  • VGI
  • Analyst Count
  • ONCY 5
  • VGI 0
  • Target Price
  • ONCY $5.00
  • VGI N/A
  • AVG Volume (30 Days)
  • ONCY 900.3K
  • VGI 46.0K
  • Earning Date
  • ONCY 11-07-2025
  • VGI 01-01-0001
  • Dividend Yield
  • ONCY N/A
  • VGI 12.66%
  • EPS Growth
  • ONCY N/A
  • VGI N/A
  • EPS
  • ONCY N/A
  • VGI N/A
  • Revenue
  • ONCY N/A
  • VGI N/A
  • Revenue This Year
  • ONCY N/A
  • VGI N/A
  • Revenue Next Year
  • ONCY N/A
  • VGI N/A
  • P/E Ratio
  • ONCY N/A
  • VGI N/A
  • Revenue Growth
  • ONCY N/A
  • VGI N/A
  • 52 Week Low
  • ONCY $0.33
  • VGI $6.68
  • 52 Week High
  • ONCY $1.51
  • VGI $7.99
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 40.09
  • VGI 52.62
  • Support Level
  • ONCY $1.16
  • VGI $7.75
  • Resistance Level
  • ONCY $1.32
  • VGI $8.00
  • Average True Range (ATR)
  • ONCY 0.07
  • VGI 0.07
  • MACD
  • ONCY -0.01
  • VGI 0.01
  • Stochastic Oscillator
  • ONCY 12.46
  • VGI 72.00

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest

Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.

Share on Social Networks: